December 2025

A technician-driven workflow implemented in a health system’s specialty pharmacy reduced high-cost oncology drug waste.

This review examines the mechanisms of therapy, summarizes the existing literature, and highlights the evolving treatment options for unresectable hepatocellular carcinoma.

Biosimilars are set to revolutionize oncology by enhancing access and affordability while maintaining safety and efficacy.

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

Project Optimus transforms cancer treatment by optimizing dosing strategies, enhancing efficacy, and reducing toxicities in modern therapies.

Oncology pharmacy evolves rapidly, emphasizing the need for pharmacists to stay informed and reflect on personal growth for better patient care.